stars 1 stars 2 stars 3

Auxogyn, Inc. is advancing the field of reproductive health through its uniquely-combined knowledge of early human developmental biology, advanced computer vision technology and best clinical practices. The company’s first product, the non-invasive Early Embryo Viability Assessment System (Eeva), provides quantitative information regarding embryo development, to assist IVF clinics in potentially selecting the best embryo(s) for transfer and optimizing the treatment path for their patients undergoing in vitro fertilization (IVF) procedures.

Auxogyn, Inc. Questions

The Auxogyn, Inc. annual revenue was $8 million in 2026.

Auxogyn, Inc. is based in Menlo Park, California.

The NAICS codes for Auxogyn, Inc. are [32, 325, 3254].

The SIC codes for Auxogyn, Inc. are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users